We are actively researching new immuno-oncology agents for cancer patients in tumor types where we see significant need and opportunity for new treatment options.
September is Ovarian Cancer Awareness Month. We stand in solidarity with patients, caregivers and family members whose lives have been impacted by Ovarian Cancer.
Meet Michele, an Alkermes employee who uses her past experience as an oncology nurse to aid in her personal mission of helping to improve patients’ lives through research.
On the heels of ASCO22, we remain committed to innovating in the oncology space, particularly for cancers with high unmet needs, like platinum-resistant ovarian cancer.
This National Women’s Health Week, Alkermes’ Director of Corporate and R&D Communications, Gretchen Murphy, shares her personal story and why regular cancer screenings are vital.
While the industry has made great strides in cancer research and treatments, minority groups in the U.S. continue to bear a greater burden of cancers compared with others.
Did you know that that there is a type of melanoma that is not visible on skin? Watch this video to learn about mucosal melanoma including treatment challenges, and unmet needs.
Did you know that that there is a type of melanoma that is not visible on skin? Watch this video to learn about mucosal melanoma including treatment challenges, and unmet needs.
While coping with the effects of cancer during the holidays is difficult, we find hope in the research work being done at Alkermes to help expand the future of cancer treatment for patients and their families.
November is National Family Caregivers Month and as we prepare for Thanksgiving, it is a perfect opportunity to express our sincerest gratitude to family caregivers.
During Ovarian Cancer Awareness Month, Alkermes employee, Kate, shares a glimpse into her personal journey with ovarian cancer, which inspires her work within the oncology space.
We are pleased to share clinical trial data on our investigational #immunooncology therapy and are excited to be a part of the 17th EADO Congress and 2021 World Mobile Congress Interactive Virtual Meeting.
This Head and Neck Cancer Awareness Month, Peter, an Alkermes employee, shares his personal connection to this type of #cancer and the immense impact it has had on an important person in his life.
April is National Cancer Control Month. At Alkermes, we are investigating new treatment options for cancer patients and raising awareness for cancer prevention.
During Womens History Month we honor Dr. Mary-Claire King, who forever changed oncology by discovering mutations to BRCA could cause genetically inherited breast cancer.
Alkermes is committed to diversity, inclusion and belonging in various aspects of our business. We are purposeful about creating an environment that...
